비침습적 뇌외상 모니터링 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)
Non-invasive Brain Trauma Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Monitoring Devices, Consumables), By End-use (Neurological Centres), By Region, And Segment Forecasts, 2024 - 2030
상품코드
:
1571467
리서치사
:
Grand View Research
발행일
:
2024년 09월
페이지 정보
:
영문 100 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
비침습적 뇌외상 모니터링 기기 시장 성장 및 동향 :
Grand View Research, Inc.의 최신 보고서에 따르면, 세계 비침습적 뇌 외상 모니터링 기기 시장 규모는 2030년까지 248억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 8.6%의 성장률을 나타낼 것으로 예상됩니다.
외상성 뇌외상(TBI)은 알츠하이머병, 파킨슨병과 같은 신경퇴행성 질환의 주요 원인으로 꼽힙니다. 이에 따라 지역 및 세계 차원에서 인지도를 높이기 위한 다양한 노력이 이루어지고 있으며, 이는 진단율을 높이고 비침습적 뇌외상 모니터링 장비의 성장을 주도하고 있습니다.
이 분야의 기술 발전은 정확성, 휴대성 및 경제성과 결합되어 업계의 성장을 뒷받침하고 있습니다. 예를 들어, 최근 출시된 경두개 도플러(TCD)와 같은 비침습적 두개내압 모니터는 정확한 위치 결정과 더 나은 압력 구배를 생성하여 치료에 더 높은 정확도를 제공합니다.
최소침습수술(MIS)은 환자의 외상이 적고 합병증을 최소화하고 회복이 빠릅니다. 비침습적 신경외과 수술에서 비침습적 뇌외상 모니터링 장비는 중요한 역할을 합니다. 따라서 MIS의 수가 증가함에 따라 업계의 성장을 주도하고 있습니다.
이 산업의 주요 타겟 인구는 60세 이상입니다. 이 계층의 인구는 TBI와 그 합병증에 걸릴 위험이 높습니다. 전 세계 노인 인구는 증가 추세에 있으며, 이 산업의 중요한 원동력이 되고 있습니다.
비침습적 뇌외상 모니터링 기기 시장 보고서 하이라이트
두개내압 모니터, MRI 스캐너, CT 스캐너, PET 스캐너, EEG, MEG를 포함한 모니터링 장비는 2023년 약 63.2%의 큰 점유율을 차지했습니다. 이 장비와 관련된 높은 비용과 이러한 장비의 사용 증가가 이 부문의 성장을 주도하고 있습니다.
제품별 부문의 소모품 하위 부문은 예측 기간 동안 유리한 성장을 보일 것으로 예상됩니다. 소모품의 반복 구매와 정기적인 유지 보수 활동은 이러한 제품에 대한 수요를 촉진할 것으로 예상됩니다.
최종 용도별 시장은 병원, 신경센터, 기타 환경으로 구분됩니다. 최종 용도별로는 병원이 전체 매출의 80.9% 이상을 차지하고 있습니다. 병원의 수술 건수가 많은 것이 성장에 기여했습니다.
북미는 2023년 비침습적 뇌 외상 모니터링 기기 시장을 장악했습니다. 선진화된 의료 시스템, 높은 인지도, 계획된 상환 정책이 이 지역 시장 성장에 기여했습니다. 그러나 아시아태평양은 예측 기간 동안 크게 성장할 것으로 예상됩니다.
이 업계에서 활동하는 주요 기업으로는 Advanced Brain Monitoring, Inc. Magstim EGI; General Electric Company; Hitachi, Ltd.
목차 제1장 조사 방법과 범위
제2장 주요 요약
제3장 비침습적 뇌외상 모니터링 기기 시장 변수, 동향, 범위
시장 서론/계통 전망
시장 규모와 성장 전망
시장 역학
시장 성장 촉진요인 분석
시장 성장 억제요인 분석
비침습적 뇌외상 모니터링 기기 시장 분석 툴
Porter의 Five Forces 분석
PESTEL 분석
제4장 비침습적 뇌외상 모니터링 기기 시장 : 제품 추정·동향 분석
부문 대시보드
비침습적 뇌외상 모니터링 기기 시장 : 제품별 변동 분석, 2023년 및 2030년
모니터링 기기
소모품
제5장 비침습적 뇌외상 모니터링 기기 시장 : 최종 용도 추정·동향 분석
부문 대시보드
비침습적 뇌외상 모니터링 기기 시장 : 최종 용도별 변동 분석, 2023년 및 2030년
병원
신경센터
기타
제6장 비침습적 뇌외상 모니터링 기기 시장 : 지역 추정·동향 분석
비침습적 뇌외상 모니터링 기기 시장 점유율, 지역별, 2023년 및 2030년
북미
유럽
영국
독일
프랑스
이탈리아
스페인
덴마크
스웨덴
노르웨이
아시아태평양
라틴아메리카
중동 및 아프리카
남아프리카공화국
사우디아라비아
아랍에미리트(UAE)
쿠웨이트
제7장 경쟁 구도
주요 시장 진출기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
Advanced Brain Monitoring, Inc.
Cadwell Industries, Inc.
Canon Medical Systems Corporations
Compumedics Ltd.
Magstim EGI
General Electric Company
Hitachi, Ltd.
Koninklijke Philips NV
Medtronic
Natus Medical Incorporated
NeuroLogica Corp.
NeuroWave Systems, Inc.
Nihon Kohden Corporation
Noraxon USA
RAUMEDIC AG
Sense Neuro
Siemens
Sophysa
Spiegelberg GmbH &Co. KG
LSH
영문 목차
Non-invasive Brain Trauma Monitoring Devices Market Growth & Trends:
The global non-invasive brain trauma monitoring devices market size is expected to reach USD 24.8 billion by 2030, registering to grow at a CAGR of 8.6% from 2024 to 2030 according to a new report by Grand View Research, Inc. The rising burden of Traumatic Brain Injuries (TBI) is a leading cause of neurodegenerative disorders such as Alzheimer's and Parkinson's disease. As a result, there are numerous initiatives taken at the regional and global levels to create awareness, which facilitated a heavy diagnosis rate, thus governing the growth of non-invasive brain trauma monitoring devices.
Technological advancements in this field are connected with accuracy, portability, and affordability, which are supporting the industry growth. For instance, recently available non-invasive intracranial pressure monitors, such as Transcranial Doppler (TCD), are accurate in positioning and creating a better pressure gradient and also bringing in more accuracy in the treatment.
The Minimally Invasive Surgeries (MIS) are less traumatic to patients and facilitate faster recovery with minimum complications. In minimally invasive neurological surgeries, non-invasive brain trauma monitoring devices play a critical role. Thus, the increasing volume of MIS is driving the industry's growth.
The key target population in this industry includes people above 60 years. This section of the population is at a greater risk for TBIs and their co-morbidities. The global geriatric population is on arise and is a vital driver for this industry.
Non-invasive Brain Trauma Monitoring Devices Market Report Highlights:
Monitoring devices that include intracranial pressure monitors, MRI scanners, CT scanners, PET scanners, EEG, and MEG held a substantial share of around 63.2% in 2023. The high costs associated with this equipment and the increasing usage of these devices governed the growth of this segment.
The consumables sub-segment in the product segment is anticipated to witness lucrative growth over the forecast period. The repeat purchase of consumables and regular maintenance activities are expected to spur the demand for these products.
The market on the basis of end-use is segmented into hospitals, neurological centers, and other settings. The hospital segment dominated the end-use segment with over 80.9% of the revenue. The greater volume of surgeries performed in hospitals contributed to its growth.
North America dominated the non-invasive brain trauma monitoring devices market in 2023. The advanced healthcare system, high awareness level, and well-planned reimbursement policies helped this market to grow in this region. However, Asia Pacific is anticipated to witness significant growth over the forecast period.
Some key players operating in this industry include Advanced Brain Monitoring, Inc.; Cadwell Industries, Inc.; Canon Medical Systems Corporation; Compumedics Ltd.; Magstim EGI; General Electric Company; Hitachi, Ltd.; Koninklijke Philips N.V.; Medtronic; Natus Medical Incorporated; NeuroLogica Corp.; NeuroWave Systems, Inc., are the key initiatives in this industry.
Table of Contents Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Non-Invasive Brain Trauma Monitoring Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Non-Invasive Brain Trauma Monitoring Devices Market Analysis Tools
3.4.1. Porter's Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Non-Invasive Brain Trauma Monitoring Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Non-Invasive Brain Trauma Monitoring Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Monitoring Devices
4.3.1. Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Intra Cranial Pressure Monitor
4.3.2.1. Intra Cranial Pressure Monitor Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. MRI Scanner
4.3.3.1. MRI Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. CT Scanner
4.3.4.1. CT Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. PET Scanner
4.3.5.1. PET Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. EEG
4.3.6.1. EEG Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.7. MEG
4.3.7.1. MEG Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.8. Others
4.3.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Consumables
4.4.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Electrodes
4.4.2.1. Electrodes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Sensors
4.4.3.1. Sensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Fibre Optic Cables
4.4.4.1. Fibre Optic Cables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Non-Invasive Brain Trauma Monitoring Devices Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Non-Invasive Brain Trauma Monitoring Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
5.3. Hospitals
5.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Neurological Centers
5.4.1. Neurological Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Non-Invasive Brain Trauma Monitoring Devices Market: Regional Estimates & Trend Analysis
6.1. Non-Invasive Brain Trauma Monitoring Devices Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East & Africa (MEA)
6.6.1. MEA Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Advanced Brain Monitoring, Inc.
7.4.1.1. Participant's Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/Strategic Initiatives
7.4.2. Cadwell Industries, Inc.
7.4.2.1. Participant's Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/Strategic Initiatives
7.4.3. Canon Medical Systems Corporations
7.4.3.1. Participant's Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/Strategic Initiatives
7.4.4. Compumedics Ltd.
7.4.4.1. Participant's Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/Strategic Initiatives
7.4.5. Magstim EGI
7.4.5.1. Participant's Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/Strategic Initiatives
7.4.6. General Electric Company
7.4.6.1. Participant's Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/Strategic Initiatives
7.4.7. Hitachi, Ltd.
7.4.7.1. Participant's Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/Strategic Initiatives
7.4.8. Koninklijke Philips N.V.
7.4.8.1. Participant's Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/Strategic Initiatives
7.4.9. Medtronic
7.4.9.1. Participant's Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/Strategic Initiatives
7.4.10. Natus Medical Incorporated
7.4.10.1. Participant's Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/Strategic Initiatives
7.4.11. NeuroLogica Corp.
7.4.11.1. Participant's Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/Strategic Initiatives
7.4.12. NeuroWave Systems, Inc.
7.4.12.1. Participant's Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/Strategic Initiatives
7.4.13. Nihon Kohden Corporation
7.4.13.1. Participant's Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Recent Developments/Strategic Initiatives
7.4.14. Noraxon USA
7.4.14.1. Participant's Overview
7.4.14.2. Financial Performance
7.4.14.3. Product Benchmarking
7.4.14.4. Recent Developments/Strategic Initiatives
7.4.15. RAUMEDIC AG
7.4.15.1. Participant's Overview
7.4.15.2. Financial Performance
7.4.15.3. Product Benchmarking
7.4.15.4. Recent Developments/Strategic Initiatives
7.4.16. Sense Neuro
7.4.16.1. Participant's Overview
7.4.16.2. Financial Performance
7.4.16.3. Product Benchmarking
7.4.16.4. Recent Developments/Strategic Initiatives
7.4.17. Siemens
7.4.17.1. Participant's Overview
7.4.17.2. Financial Performance
7.4.17.3. Product Benchmarking
7.4.17.4. Recent Developments/Strategic Initiatives
7.4.18. Sophysa
7.4.18.1. Participant's Overview
7.4.18.2. Financial Performance
7.4.18.3. Product Benchmarking
7.4.18.4. Recent Developments/Strategic Initiatives
7.4.19. Spiegelberg GmbH & Co. KG
7.4.19.1. Participant's Overview
7.4.19.2. Financial Performance
7.4.19.3. Product Benchmarking
7.4.19.4. Recent Developments/Strategic Initiatives
관련자료
